Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case

Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment. As it's extremely rare, there is no evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Buero, Agustín, Quadrelli, Silvia, Pankl, Leonardo German, Vigovich, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689853/
https://www.ncbi.nlm.nih.gov/pubmed/31448016
http://dx.doi.org/10.11604/pamj.2019.33.53.12401
_version_ 1783443100334555136
author Buero, Agustín
Quadrelli, Silvia
Pankl, Leonardo German
Vigovich, Felix
author_facet Buero, Agustín
Quadrelli, Silvia
Pankl, Leonardo German
Vigovich, Felix
author_sort Buero, Agustín
collection PubMed
description Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment. As it's extremely rare, there is no evidence of the impact of different modalities of treatment. There are no reported cases that did not include surgery as part of their management. We herein present a case of an unresectable thymic basaloid carcinoma treated only with concurrent chemotherapy and radiotherapy that obtained a complete remission and free of disease after 2 years.
format Online
Article
Text
id pubmed-6689853
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-66898532019-08-23 Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case Buero, Agustín Quadrelli, Silvia Pankl, Leonardo German Vigovich, Felix Pan Afr Med J Case Report Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment. As it's extremely rare, there is no evidence of the impact of different modalities of treatment. There are no reported cases that did not include surgery as part of their management. We herein present a case of an unresectable thymic basaloid carcinoma treated only with concurrent chemotherapy and radiotherapy that obtained a complete remission and free of disease after 2 years. The African Field Epidemiology Network 2019-05-24 /pmc/articles/PMC6689853/ /pubmed/31448016 http://dx.doi.org/10.11604/pamj.2019.33.53.12401 Text en © Agustín Buero et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Buero, Agustín
Quadrelli, Silvia
Pankl, Leonardo German
Vigovich, Felix
Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title_full Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title_fullStr Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title_full_unstemmed Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title_short Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
title_sort two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689853/
https://www.ncbi.nlm.nih.gov/pubmed/31448016
http://dx.doi.org/10.11604/pamj.2019.33.53.12401
work_keys_str_mv AT bueroagustin twoyeardiseaseremissionofanunresectablebasaloidthymiccarcinomawithsecondlinechemotherapydrugsreportofacase
AT quadrellisilvia twoyeardiseaseremissionofanunresectablebasaloidthymiccarcinomawithsecondlinechemotherapydrugsreportofacase
AT panklleonardogerman twoyeardiseaseremissionofanunresectablebasaloidthymiccarcinomawithsecondlinechemotherapydrugsreportofacase
AT vigovichfelix twoyeardiseaseremissionofanunresectablebasaloidthymiccarcinomawithsecondlinechemotherapydrugsreportofacase

Ejemplares similares